Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Metoprolol Succinate Patent Expiration

Metoprolol Succinate was first introduced by Toprol Acquisition Llc in its drug Toprol-Xl on Jan 10, 1992. Another drug containing Metoprolol Succinate is Kapspargo Sprinkle. 26 different companies have introduced drugs containing Metoprolol Succinate.


Metoprolol Succinate Patents

Given below is the list of patents protecting Metoprolol Succinate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Kapspargo Sprinkle US9504655 Capsule dosage form of metoprolol succinate Jul 09, 2035 Spil
Kapspargo Sprinkle US9700530 Capsule dosage form of metoprolol succinate Jul 09, 2035 Spil



Metoprolol Succinate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Metoprolol Succinate Generic API Manufacturers

Several generic applications have been filed for Metoprolol Succinate. The first generic version for Metoprolol Succinate was by Sandoz and was approved on Jul 31, 2006. And the latest generic version is by Ipca Laboratories Ltd and was approved on Jun 25, 2025.

Given below is the list of companies who have filed for Metoprolol Succinate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Oct 18, 2022
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Oct 18, 2022
EQ 50MG TARTRATE

tablet, extended release Discontinued ORAL N/A Oct 18, 2022
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Oct 18, 2022





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2016
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2016
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2016
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2016


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 3, 2009
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 3, 2009
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Apr 15, 2010
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Apr 15, 2010





4. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 25, 2020





5. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Oct 26, 2018
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Oct 26, 2018
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Oct 26, 2018


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Vasco Da Gama Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Raigad Cipla Limited
Bengaluru Cipla Limited
Mumbai Cipla Limited
Bangalore Cipla Ltd.
Pithampur, District Dhar Cipla Limited





6. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 1, 2012
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 1, 2012





7. GRANULES

Granules India Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 7, 2023
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 7, 2023
EQ 50MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 7, 2023
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 7, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Manassas Granules Consumer Health Inc.
Chantilly Granules Pharmaceuticals Inc.
India
Sangareddy District Granules India Limited
Secunderabad Granules India Limited
Parawada Mandal Granules India Limited
Visakhapatnam Granules India Limited
Medchal-Malkhajgiri District Granules India Limited





8. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 6, 2020
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 6, 2020
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 6, 2020
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 6, 2020





9. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Jun 25, 2025
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Jun 25, 2025
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Jun 25, 2025
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Jun 25, 2025





10. LUPIN

Lupin Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 15, 2023
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 15, 2023
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 15, 2023
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Aug 15, 2023


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.
Vasco Da Gama Lupin Limited
Pithampur Lupin Limited
Navi Mumbai LUPIN LIMITED
Mumbai Lupin Limited
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Anakapalli District Lupin Manufacturing Solutions Limited
Tarapur, Thane Lupin Limited
Nagpur Lupin Limited
Pithampur Lupin Limited (Unit 1)
Mandideep Lupin Limited
Mandideep Lupin Limited (Unit II)
Pune Lupin Bioresearch Center
Pirangut Lupin Limited
United States
Baltimore Lupin Pharmaceuticals Inc.
Coral Springs Lupin Research Inc





11. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 15, 2011
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 15, 2011
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 15, 2011
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 15, 2011





12. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A May 18, 2007
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A May 18, 2007
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Mar 20, 2008
EQ 50MG TARTRATE

tablet, extended release Discontinued ORAL N/A May 14, 2008





13. NOVAST LABS

Novast Laboratories Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 6, 2018
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 6, 2018
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 6, 2018
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 6, 2018





14. PHARMADAX INC

Pharmadax Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Pharmadax Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 30, 2020
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 30, 2020
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 31, 2020
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 31, 2020


Manufacturing Plant Locations
New

Pharmadax Inc's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Pharmadax Inc as present at those locations.

Country City Firm Name
Taiwan
New Taipei City Pharmadax Inc.





15. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Jan 4, 2022
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Jan 4, 2022





16. REDDYS

Doctor Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 15, 2012
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 15, 2012





17. SANDOZ

Sandoz has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG TARTRATE

tablet, extended release Discontinued ORAL N/A Jul 31, 2006
EQ 50MG TARTRATE

tablet, extended release Discontinued ORAL N/A May 18, 2007
EQ 100MG TARTRATE

tablet, extended release Discontinued ORAL N/A Mar 20, 2008
EQ 200MG TARTRATE

tablet, extended release Discontinued ORAL N/A Mar 20, 2008


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





18. SUNSHINE

Sunshine Lake Pharma Co Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Sunshine.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Sep 26, 2022
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Sep 26, 2022
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Sep 26, 2022
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB May 23, 2024


Manufacturing Plant Locations
New

Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.

Country City Firm Name
United States
Doral Sunshine Bottling Co, Inc.
North Las Vegas Sunshine Fresh Nevada LLC
Indianapolis SUNSHINE INTERNATIONAL LLC
Alhambra Sunshine Bakery
Rochester Sunshine Fund Raising Co.
Tupelo Sunshine Mills, Inc.
Maumee Sunshine Inc Of Nw Ohio
Glenwood Springs Sunshine & Moons, LLC
Columbus Sunshine Apiaries
Bridgeville Sunshine Burger & Specialty Food Company, LLC
Dublin Sunshine Mills, Inc
Portland Sunshine Dairy Foods Management LLC
Halifax Sunshine Mills, Inc.
Artesia Sunshine Evergreen Inc.
Jacksonville Sunshine Peanut Company
Methuen Sunshine International Foods, Inc.
Red Bay Sunshine Mills aka World Pet Care
Andrews Sunshine Dairy, LLC
Augusta Sunshine Honey Inc.
Evergreen Sunshine Honey Bees LLC
Peru
Tambogrande Sunshine Export S.A.C
India
Surat Sunshine Global Hospital
Thailand
Tha Mai Sunshine International
China
Dongguan Sunshine Lake Pharma Co., Ltd
Mozambique
Boane Sunshine Nut Limitada





19. VISUM PHARM

Visum Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Visum Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 19, 2018
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 19, 2018
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 19, 2018
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Dec 19, 2018


Manufacturing Plant Locations
New

Visum Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Visum Pharm as present at those locations.

Country City Firm Name
China
Haikou Visum Pharmaceutical Co Ltd





20. WATSON LABS FLORIDA

Watson Laboratories Inc Florida has filed for 1 generic for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Watson Labs Florida.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 3, 2009





21. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 22, 2010
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 22, 2010
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 22, 2010
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 22, 2010





22. YICHANG HUMANWELL

Yichang Humanwell Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 12, 2021
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Feb 12, 2021
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Nov 8, 2021
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Aug 1, 2022


Manufacturing Plant Locations
New

Yichang Humanwell's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yichang Humanwell as present at those locations.

Country City Firm Name
China
Yichang Yichang Humanwell Oral Solid Dosage Plant





23. ZHEJIANG JUTAI PHARM

Zhejiang Jutai Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Zhejiang Jutai Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 26, 2024
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 26, 2024
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Jul 26, 2024





24. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Metoprolol Succinate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 23, 2018
EQ 200MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 23, 2018
EQ 100MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 23, 2018
EQ 25MG TARTRATE

tablet, extended release Prescription ORAL AB Mar 23, 2018